A

Adicon Holdings Ltd
HKEX:9860

Watchlist Manager
Adicon Holdings Ltd
HKEX:9860
Watchlist
Price: 6.24 HKD -2.65% Market Closed
Market Cap: 4.5B HKD
Have any thoughts about
Adicon Holdings Ltd?
Write Note

Adicon Holdings Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Adicon Holdings Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
A
Adicon Holdings Ltd
HKEX:9860
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Long-Term Investments
ÂĄ580.7m
CAGR 3-Years
19%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Long-Term Investments
ÂĄ1.3B
CAGR 3-Years
35%
CAGR 5-Years
18%
CAGR 10-Years
57%
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Long-Term Investments
ÂĄ2.8B
CAGR 3-Years
17%
CAGR 5-Years
12%
CAGR 10-Years
3%
Dian Diagnostics Group Co Ltd
SZSE:300244
Long-Term Investments
ÂĄ985.9m
CAGR 3-Years
-8%
CAGR 5-Years
2%
CAGR 10-Years
57%
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Long-Term Investments
ÂĄ2.1B
CAGR 3-Years
0%
CAGR 5-Years
9%
CAGR 10-Years
74%
No Stocks Found

Adicon Holdings Ltd
Glance View

Market Cap
4.5B HKD
Industry
Health Care

ADICON Holdings Ltd. engages in the provision of independent clinical laboratory services. The company is headquartered in Hangzhou, Zhejiang and currently employs 6,128 full-time employees. The company went IPO on 2023-06-30. The firm primarily provides testing services to hospitals, medical institutions, medical examination centers, consumers, pharmaceutical companies and contract research organizations (CROs). The firm's inspection services mainly include routine tests, esoteric tests, clinical immunologic testing, clinical chemistry testing, clinical molecular biology testing, pathology testing and others testing. The firm is also engaged in the sales of medical testing equipment. The firm principally conducts its businesses in the domestic market.

Intrinsic Value
9.48 HKD
Undervaluation 34%
Intrinsic Value
Price
A

See Also

Back to Top